ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
ECTE was delisted on the 11th of July, 2016.
2 hedge funds and large institutions have $1K invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
0% more capital invested
Capital invested by funds: $1K → $1K ($0)
Top Buyers
Top Sellers
ECTE Hedge Fund Activity: Q4 2017 in Review
2 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q4 2017, worth a combined $1K — unchanged from a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ECTE positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
- 2 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q4 2017, up from 1 in Q3 2017.
- Funds reported $1K of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q4 2017, unchanged quarter-over-quarter.
- 1 fund opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q4 2017 and 0 closed out, a net change of +1 holder.
Based on aggregated 13F filings for Q4 2017.